Humoral immune responses associated with control of SARS-CoV-2 breakthrough infections in a vaccinated US military population
Gregory D. Gromowski(Walter Reed Army Institute of Research), Kristina K. Peachman(Walter Reed Army Institute of Research), Jennifer Enoch(Henry M. Jackson Foundation), Diane E. Epperson(Booz Allen Hamilton (United States)), Jeffrey R. Currier(Walter Reed Army Institute of Research), Dominic Paquin‐Proulx(Henry M. Jackson Foundation), Sheila A. Peel(Henry M. Jackson Foundation), Michael K. McCracken(Walter Reed Army Institute of Research), Camila Macedo Cincotta(Henry M. Jackson Foundation), Sandra V. Mayer(Walter Reed Army Institute of Research), Dante Coleman(Henry M. Jackson Foundation), Jocelyn King(Walter Reed Army Institute of Research), Janice M. Darden(Henry M. Jackson Foundation), Isabella Swafford(Walter Reed Army Institute of Research), Casey K. Storme(Walter Reed Army Institute of Research), Jason F. Okulicz(Gilead Sciences (United States)), Kelly T. McKee(GeoVax (United States)), Jessica Cowden
Cited by 12
Related Papers
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Standardization of cytokine flow cytometry assays
|BMC Immunology|2005|240
Epidemiology and clinical characteristics of elite controllers
|Current Opinion in HIV and AIDS|2011|176